Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IntelligeneROCO:7832 +3.73%11 Gross Margin % is 24.12% as of Dec. 2025, which is 0% below its 10-year median of 24.20. GuruFocus rates ROCO:7832 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 732 Biotechnology companies, Intelligene ranks worse than 80.87% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Intelligene had a gross margin of 24.12% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Intelligene Gross Margin % Related Terms
Intelligene Gross Margin % Historical Data
* Premium members only.
The historical data trend for Intelligene's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7832 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Intelligene's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligene Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Intelligene's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Intelligene's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Intelligene (ROCO:7832) has a Gross Margin % of 24.12% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Intelligene and its competitors. This is near median its historical median of 24.20. Over the past decade, Intelligene's Gross Margin % has ranged from 9.11 to 28.65. According to the industry distribution chart, Intelligene ranks #592 out of 732 companies in the Biotechnology industry, placing it in the top 80.9%.
Is Intelligene's Gross Margin % too high?
Intelligene's current Gross Margin % of 24.12% is near median its 10-year median of 24.20. Over the past 10 years, this metric has ranged from a low of 9.11 to a high of 28.65. The Biotechnology industry median Gross Margin % is 60.91. Intelligene's value of 24.12% is 60.4% below this industry median. Based on the distribution chart, Intelligene ranks #592 out of 732 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Intelligene has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Intelligene's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Intelligene ranks #592 out of 732 companies for Gross Margin %. This places Intelligene in the lower half of its industry. The industry median Gross Margin % is 60.91. Intelligene's value of 24.12% is 60.4% below this benchmark. Historically, Intelligene's own Gross Margin % has ranged from 9.11 to 28.65 over the past decade. While the company's 10-year median is 24.20 vs. the industry median of 60.91, Intelligene has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intelligene's current Gross Margin % of 24.12% is 60.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Intelligene and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intelligene's current Gross Margin % is 24.12%, which is near median its own 10-year median of 24.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligene stock overvalued right now?
Intelligene (ROCO:7832) has a current Gross Margin % of 24.12%. The current Gross Margin % is 24.12%, which is near median its 10-year median of 24.20 and 60.4% below the Biotechnology industry median of 60.91. Intelligene's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Intelligene (ROCO:7832), the current Gross Margin % is 24.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Intelligene Inc is one of the pioneering drug development companies in Taiwan's biotechnology sector. It is at the forefront of advancing gene therapeutics through siRNA-based drugs, utilizing a revolutionary approach that harnesses the power of RNA interference technology to combat formidable adversaries. Its mission is to confront the looming threats of pandemics and influenza. Its products include IG-001 for Coronavirus Disease (SARS-CoV-2), and IG-002 for Flu.
11GF Score
Get the complete analysis for ROCO:7832
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7832 has been successfully added to your 
